Congenital Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of the Upper Extremity

authors:

avatar Li Wang 1 , 2 , avatar Xibiao Yang 3 , avatar Zhongcheng Han 4 , avatar Chuying Huang 2 , 5 , *

Department of Medical Dermatology, Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Enshi, China
Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, China
Department of Radiology, West China Hospital of Sichuan University, Chengdu, China
Department of Medical Oncology, Xinjiang Uygur Autonomous Region People's Hospital, Xinjiang Uygur Autonomous Region, China
Department of Medical Oncology, Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Enshi, China

how to cite: Wang L, Yang X, Han Z, Huang C. Congenital Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of the Upper Extremity. Iran J Pediatr. 2015;25(6):e3800. https://doi.org/10.5812/ijp.3800.

References

  • 1.

    Suva ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, et al. Identification of cancer stem cells in Ewing's sarcoma. Cancer Res. 2009;69(5):1776-81. [PubMed ID: 19208848]. https://doi.org/10.1158/0008-5472.CAN-08-2242.

  • 2.

    Cidre-Aranaz F, Alonso J. EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma. Front Oncol. 2015;5:162. [PubMed ID: 26258070]. https://doi.org/10.3389/fonc.2015.00162.

  • 3.

    Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2124-35. [PubMed ID: 16919776]. https://doi.org/10.1016/j.ejca.2006.05.015.

  • 4.

    Wong T, Goldsby RE, Wustrack R, Cash T, Isakoff MS, DuBois SG. Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age. Pediatr Blood Cancer. 2015;62(11):1947-51. [PubMed ID: 26173989]. https://doi.org/10.1002/pbc.25635.

  • 5.

    Yasuda T, Inagaki T, Yamanouchi Y, Kawamoto K, Kohdera U, Kawasaki H, et al. A case of primary Ewing's sarcoma of the occipital bone presenting with obstructive hydrocephalus. Childs Nerv Syst. 2003;19(12):792-9. [PubMed ID: 14586633]. https://doi.org/10.1007/s00381-003-0816-z.

  • 6.

    Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol. 2009;27(15):2536-41. [PubMed ID: 19349548]. https://doi.org/10.1200/JCO.2008.19.1478.

  • 7.

    Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, et al. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer. 2011;117(13):3027-32. [PubMed ID: 21692057]. https://doi.org/10.1002/cncr.25840.

  • 8.

    Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, et al. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Ann Oncol. 2011;22(5):1221-7. [PubMed ID: 21059639]. https://doi.org/10.1093/annonc/mdq573.

  • 9.

    Krasin MJ, Davidoff AM, Rodriguez-Galindo C, Billups CA, Fuller CE, Neel MD, et al. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors. Cancer. 2005;104(2):367-73. [PubMed ID: 15948159]. https://doi.org/10.1002/cncr.21160.

  • 10.

    De Ioris MA, Prete A, Cozza R, Podda M, Manzitti C, Pession A, et al. Ewing sarcoma of the bone in children under 6 years of age. PLoS One. 2013;8(1). e53223. [PubMed ID: 23382839]. https://doi.org/10.1371/journal.pone.0053223.

  • 11.

    Duchman KR, Gao Y, Miller BJ. Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database. Cancer Epidemiol. 2015;39(2):189-95. [PubMed ID: 25595632]. https://doi.org/10.1016/j.canep.2014.12.012.

  • 12.

    Jurgens H, Exner U, Gadner H, Harms D, Michaelis J, Sauer R, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer. 1988;61(1):23-32. [PubMed ID: 3334950].

  • 13.

    Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, et al. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;51(3):334-8. [PubMed ID: 18506764]. https://doi.org/10.1002/pbc.21618.